Myocardial perfusion 320-row multidetector computed tomography-guided treatment strategy for the clinical management of patients with recent acute-onset chest pain: Design of the CArdiac cT in the treatment of acute CHest pain (CATCH)-2 randomized controlled trial

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Myocardial perfusion 320-row multidetector computed tomography-guided treatment strategy for the clinical management of patients with recent acute-onset chest pain : Design of the CArdiac cT in the treatment of acute CHest pain (CATCH)-2 randomized controlled trial. / Sørgaard, Mathias; Linde, Jesper J; Hove, Jens D; Petersen, Jan R; Jørgensen, Tem B S; Abdulla, Jawdat; Heitmann, Merete; Kragelund, Charlotte; Hansen, Thomas Fritz; Udholm, Patricia M; Pihl, Christian; Kühl, J Tobias; Engstrøm, Thomas; Jensen, Jan Skov; Høfsten, Dan E; Kelbæk, Henning; Kofoed, Klaus F.

In: American Heart Journal, Vol. 179, 09.2016, p. 127-135.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Sørgaard, M, Linde, JJ, Hove, JD, Petersen, JR, Jørgensen, TBS, Abdulla, J, Heitmann, M, Kragelund, C, Hansen, TF, Udholm, PM, Pihl, C, Kühl, JT, Engstrøm, T, Jensen, JS, Høfsten, DE, Kelbæk, H & Kofoed, KF 2016, 'Myocardial perfusion 320-row multidetector computed tomography-guided treatment strategy for the clinical management of patients with recent acute-onset chest pain: Design of the CArdiac cT in the treatment of acute CHest pain (CATCH)-2 randomized controlled trial', American Heart Journal, vol. 179, pp. 127-135. https://doi.org/10.1016/j.ahj.2016.05.016

APA

Sørgaard, M., Linde, J. J., Hove, J. D., Petersen, J. R., Jørgensen, T. B. S., Abdulla, J., Heitmann, M., Kragelund, C., Hansen, T. F., Udholm, P. M., Pihl, C., Kühl, J. T., Engstrøm, T., Jensen, J. S., Høfsten, D. E., Kelbæk, H., & Kofoed, K. F. (2016). Myocardial perfusion 320-row multidetector computed tomography-guided treatment strategy for the clinical management of patients with recent acute-onset chest pain: Design of the CArdiac cT in the treatment of acute CHest pain (CATCH)-2 randomized controlled trial. American Heart Journal, 179, 127-135. https://doi.org/10.1016/j.ahj.2016.05.016

Vancouver

Sørgaard M, Linde JJ, Hove JD, Petersen JR, Jørgensen TBS, Abdulla J et al. Myocardial perfusion 320-row multidetector computed tomography-guided treatment strategy for the clinical management of patients with recent acute-onset chest pain: Design of the CArdiac cT in the treatment of acute CHest pain (CATCH)-2 randomized controlled trial. American Heart Journal. 2016 Sep;179:127-135. https://doi.org/10.1016/j.ahj.2016.05.016

Author

Sørgaard, Mathias ; Linde, Jesper J ; Hove, Jens D ; Petersen, Jan R ; Jørgensen, Tem B S ; Abdulla, Jawdat ; Heitmann, Merete ; Kragelund, Charlotte ; Hansen, Thomas Fritz ; Udholm, Patricia M ; Pihl, Christian ; Kühl, J Tobias ; Engstrøm, Thomas ; Jensen, Jan Skov ; Høfsten, Dan E ; Kelbæk, Henning ; Kofoed, Klaus F. / Myocardial perfusion 320-row multidetector computed tomography-guided treatment strategy for the clinical management of patients with recent acute-onset chest pain : Design of the CArdiac cT in the treatment of acute CHest pain (CATCH)-2 randomized controlled trial. In: American Heart Journal. 2016 ; Vol. 179. pp. 127-135.

Bibtex

@article{e156ff28da854061b996c11c53de8378,
title = "Myocardial perfusion 320-row multidetector computed tomography-guided treatment strategy for the clinical management of patients with recent acute-onset chest pain: Design of the CArdiac cT in the treatment of acute CHest pain (CATCH)-2 randomized controlled trial",
abstract = "AIMS: Patients admitted with chest pain are a diagnostic challenge because the majority does not have coronary artery disease (CAD). Assessment of CAD with coronary computed tomography angiography (CCTA) is safe, cost-effective, and accurate, albeit with a modest specificity. Stress myocardial computed tomography perfusion (CTP) has been shown to increase the specificity when added to CCTA, without lowering the sensitivity. This article describes the design of a randomized controlled trial, CATCH-2, comparing a clinical diagnostic management strategy of CCTA alone against CCTA in combination with CTP.METHODS: Patients with acute-onset chest pain older than 50 years and with at least one cardiovascular risk factor for CAD are being prospectively enrolled to this study from 6 different clinical sites since October 2013. A total of 600 patients will be included. Patients are randomized 1:1 to clinical management based on CCTA or on CCTA in combination with CTP, determining the need for further testing with invasive coronary angiography including measurement of the fractional flow reserve in vessels with coronary artery lesions. Patients are scanned with a 320-row multidetector computed tomography scanner. Decisions to revascularize the patients are taken by the invasive cardiologist independently of the study allocation. The primary end point is the frequency of revascularization. Secondary end points of clinical outcome are also recorded.DISCUSSION: The CATCH-2 will determine whether CCTA in combination with CTP is diagnostically superior to CCTA alone in the management of patients with acute-onset chest pain.",
author = "Mathias S{\o}rgaard and Linde, {Jesper J} and Hove, {Jens D} and Petersen, {Jan R} and J{\o}rgensen, {Tem B S} and Jawdat Abdulla and Merete Heitmann and Charlotte Kragelund and Hansen, {Thomas Fritz} and Udholm, {Patricia M} and Christian Pihl and K{\"u}hl, {J Tobias} and Thomas Engstr{\o}m and Jensen, {Jan Skov} and H{\o}fsten, {Dan E} and Henning Kelb{\ae}k and Kofoed, {Klaus F}",
note = "Copyright {\textcopyright} 2015 Elsevier Inc. All rights reserved.",
year = "2016",
month = sep,
doi = "10.1016/j.ahj.2016.05.016",
language = "English",
volume = "179",
pages = "127--135",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",

}

RIS

TY - JOUR

T1 - Myocardial perfusion 320-row multidetector computed tomography-guided treatment strategy for the clinical management of patients with recent acute-onset chest pain

T2 - Design of the CArdiac cT in the treatment of acute CHest pain (CATCH)-2 randomized controlled trial

AU - Sørgaard, Mathias

AU - Linde, Jesper J

AU - Hove, Jens D

AU - Petersen, Jan R

AU - Jørgensen, Tem B S

AU - Abdulla, Jawdat

AU - Heitmann, Merete

AU - Kragelund, Charlotte

AU - Hansen, Thomas Fritz

AU - Udholm, Patricia M

AU - Pihl, Christian

AU - Kühl, J Tobias

AU - Engstrøm, Thomas

AU - Jensen, Jan Skov

AU - Høfsten, Dan E

AU - Kelbæk, Henning

AU - Kofoed, Klaus F

N1 - Copyright © 2015 Elsevier Inc. All rights reserved.

PY - 2016/9

Y1 - 2016/9

N2 - AIMS: Patients admitted with chest pain are a diagnostic challenge because the majority does not have coronary artery disease (CAD). Assessment of CAD with coronary computed tomography angiography (CCTA) is safe, cost-effective, and accurate, albeit with a modest specificity. Stress myocardial computed tomography perfusion (CTP) has been shown to increase the specificity when added to CCTA, without lowering the sensitivity. This article describes the design of a randomized controlled trial, CATCH-2, comparing a clinical diagnostic management strategy of CCTA alone against CCTA in combination with CTP.METHODS: Patients with acute-onset chest pain older than 50 years and with at least one cardiovascular risk factor for CAD are being prospectively enrolled to this study from 6 different clinical sites since October 2013. A total of 600 patients will be included. Patients are randomized 1:1 to clinical management based on CCTA or on CCTA in combination with CTP, determining the need for further testing with invasive coronary angiography including measurement of the fractional flow reserve in vessels with coronary artery lesions. Patients are scanned with a 320-row multidetector computed tomography scanner. Decisions to revascularize the patients are taken by the invasive cardiologist independently of the study allocation. The primary end point is the frequency of revascularization. Secondary end points of clinical outcome are also recorded.DISCUSSION: The CATCH-2 will determine whether CCTA in combination with CTP is diagnostically superior to CCTA alone in the management of patients with acute-onset chest pain.

AB - AIMS: Patients admitted with chest pain are a diagnostic challenge because the majority does not have coronary artery disease (CAD). Assessment of CAD with coronary computed tomography angiography (CCTA) is safe, cost-effective, and accurate, albeit with a modest specificity. Stress myocardial computed tomography perfusion (CTP) has been shown to increase the specificity when added to CCTA, without lowering the sensitivity. This article describes the design of a randomized controlled trial, CATCH-2, comparing a clinical diagnostic management strategy of CCTA alone against CCTA in combination with CTP.METHODS: Patients with acute-onset chest pain older than 50 years and with at least one cardiovascular risk factor for CAD are being prospectively enrolled to this study from 6 different clinical sites since October 2013. A total of 600 patients will be included. Patients are randomized 1:1 to clinical management based on CCTA or on CCTA in combination with CTP, determining the need for further testing with invasive coronary angiography including measurement of the fractional flow reserve in vessels with coronary artery lesions. Patients are scanned with a 320-row multidetector computed tomography scanner. Decisions to revascularize the patients are taken by the invasive cardiologist independently of the study allocation. The primary end point is the frequency of revascularization. Secondary end points of clinical outcome are also recorded.DISCUSSION: The CATCH-2 will determine whether CCTA in combination with CTP is diagnostically superior to CCTA alone in the management of patients with acute-onset chest pain.

U2 - 10.1016/j.ahj.2016.05.016

DO - 10.1016/j.ahj.2016.05.016

M3 - Journal article

C2 - 27595687

VL - 179

SP - 127

EP - 135

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

ER -

ID: 173478661